Brown Miller Wealth Management LLC Has $3.09 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Brown Miller Wealth Management LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% during the fourth quarter, Holdings Channel reports. The fund owned 6,110 shares of the healthcare conglomerate’s stock after selling 26 shares during the quarter. UnitedHealth Group comprises about 1.2% of Brown Miller Wealth Management LLC’s holdings, making the stock its 22nd biggest holding. Brown Miller Wealth Management LLC’s holdings in UnitedHealth Group were worth $3,091,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Howard Capital Management Group LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at $341,000. Principal Financial Group Inc. lifted its position in shares of UnitedHealth Group by 11.3% during the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock worth $1,039,933,000 after buying an additional 180,479 shares during the last quarter. Cable Hill Partners LLC lifted its position in shares of UnitedHealth Group by 22.2% during the 3rd quarter. Cable Hill Partners LLC now owns 2,687 shares of the healthcare conglomerate’s stock worth $1,571,000 after buying an additional 488 shares during the last quarter. Plato Investment Management Ltd lifted its position in shares of UnitedHealth Group by 4.8% during the 3rd quarter. Plato Investment Management Ltd now owns 23,266 shares of the healthcare conglomerate’s stock worth $13,589,000 after buying an additional 1,070 shares during the last quarter. Finally, Fortis Capital Management LLC lifted its position in shares of UnitedHealth Group by 4.2% during the 3rd quarter. Fortis Capital Management LLC now owns 8,920 shares of the healthcare conglomerate’s stock worth $5,216,000 after buying an additional 357 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $480.79 on Friday. The company has a market capitalization of $439.78 billion, a P/E ratio of 31.02, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The business has a fifty day simple moving average of $511.85 and a two-hundred day simple moving average of $551.01.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the company posted $5.83 EPS. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.75%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on UNH. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a report on Friday, January 10th. Oppenheimer increased their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Finally, KeyCorp reaffirmed an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Buy” and an average target price of $629.32.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.